The page is the record's research on the issuer — no analyst, no rating, no view. # Compass Therapeutics, Inc. (NASDAQ: CMPX) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Compass Therapeutics, Inc., listed on NASDAQ under ticker CMPX, ISIN US20454B1044. The LEI is not on the record, as no GLEIF record carries the exact legal name in jurisdiction US-DE. The security type is Corporate, the segment is not on the record, the sector is 2836 Biological Products, (No Diagnostic Substances), and the jurisdiction is United States, Delaware. The issuer is listed and not halted. ## The disclosure read The record holds 52 filings in the twelve months to 2026-11-08, across 28 filing days. Filings by type are: directors_dealings 23, regulatory_filing 14, results 7, agm_egm 3, corporate_news 3, ad_hoc 1, prospectus 1. The median gap between filing days is 7 days. The latest filing is dated 2026-10-02 and is of type directors_dealings, 37 days before the record date. The NASDAQ peer median gap is 6.0 days, the NASDAQ peer median latency is 5.0 days, and the NASDAQ peer median filings is 52. The sector peer median gap is 5.5 days, the sector peer median latency is 4.0 days, and the sector peer median filings is 65.5. ## Auditor The auditor of record is CohnReznick LLP, located in Melville, NY, U.S.A. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The issuer is listed and not halted. ## Orderability The outcome is not determinable, as the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, with the chapter as of 2026-11-04. ## Coverage No research houses were found on the issuer's investor-relations pages read. ## Open research No openly published research notes were found on the record. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer is held in sealed years 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001738021.json (identity.jurisdiction) - https://mcp.us-cm-kg.ai/events/NASDAQ/CMPX (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://www.sec.gov/Archives/edgar/data/1738021/000117184326001337/cmpx20251231_10k.htm (the auditor) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/CMPX (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/CMPX · public-record only · the same page signed and receipted: get_research at https://mcp.getissuer.ai/mcp